Dr. Anna Dewan, MD

Dr. Dewan practices at Nashville General Hospital in Nashville, Tennessee, part of Nashville General Hospital.

Dr. Dewan's NPI, 1245596394, was assigned on April 3, 2012. Dr. Dewan graduated from Yale School of Medicine in 2012. Dr. Dewan holds Tennessee license 53651.

Dr. Dewan's primary practice is Nashville General Hospital, at 1818 Albion Street, Nashville, TN 37208 in Davidson County. The practice phone is (615) 341-4490.

Dr. Dewan's primary practice is Nashville General Hospital in Nashville, Tennessee, part of Nashville General Hospital. Dr. Dewan is also affiliated with Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Dewan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dewan practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Dewan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dewan is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dewan's licenses on file in 3 states: Tennessee, Alabama and Massachusetts.

Dmand AI lists acne, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives, itchy rashes and minor injury to a limb among the conditions Dr. Dewan treats.

CMS data shows 2,440 Medicare services from Dr. Dewan across 16 procedure codes in 2024, for 484 Medicare patients. Medicare paid $64,766 for them.

CMS counts 484 Medicare patients who saw Dr. Dewan in 2024. The largest group is 65 to 74, with 236 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dewan's median patient age at 69, with 65% women.

In 2024, Dr. Dewan wrote 643 Medicare Part D claims for 190 patients. 64% of them were for generic drugs. CMS names the drug for 522 of them, across 19 drugs with 11 or more claims each, at $1,525,029 in total drug cost. In 2023, CMS named 421 claims across 15 drugs.

Dr. Dewan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 348 procedures of skin biopsy by Dr. Dewan, more than 92% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 49 papers to Dr. Dewan, published from 2015 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Skin, Immune Checkpoint Inhibitors and Dermatology. Dr. Dewan has published most often in J Am Acad Dermatol. Dr. Dewan's most frequent co-authors are Alan Stuart Boyd, MD, Steven Tze-Wei Chen, MD, MPH and Matthew S. Davids, MD.

CMS Open Payments shows 1 general payment to Dr. Dewan from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $111.

Dr. Dewan graduated from Yale School of Medicine in 2012. Dr. Dewan is a member of AAD, Medical Dermatology Society, Tennessee Dermatology Society and Women's Dermatologic Society.

Dr. Dewan is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.